HDFC Bank Limited vs Humana Inc.: Strategic Comparison

This in-depth comparison examines HDFC Bank Limited and Humana Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching HDFC Bank Limited on its own, evaluating Humana Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between HDFC Bank Limited and Humana Inc. is widest.

On the headline numbers, HDFC Bank Limited reports annual revenue of ~$32.9B against $129.7B for Humana Inc., while their respective market capitalizations stand at $118.8B and $48.2B. HDFC Bank Limited is headquartered in India and Humana Inc. in United States, and those different home markets shape how each company competes.

HDFC Bank Limited: HDFC Bank is India's largest private-sector bank by assets and deposits. Promoted by mortgage lender HDFC Ltd in 1994 and built under Aditya Puri's 26-year tenure into a byword for credit discipline, it absorbed its own parent in July 2023, adding a large home-loan book and subsidiaries in insurance and asset management. Today it serves retail, small-business and corporate customers through 9,689 branches and DBUs and a heavily digital channel mix.

Humana Inc.: Humana Inc. is a Fortune 50 health company headquartered in Louisville, Kentucky. It serves roughly 7.2 million individual and group Medicare Advantage members, millions of stand-alone Part D, Medicaid, and TRICARE beneficiaries, and patients of its CenterWell clinics, pharmacy, and home health services. Unlike diversified rivals, Humana gets nearly all of its medical membership from government-funded programs, so it is effectively a bet on Medicare Advantage and senior care.

HDFC Bank Limited and Humana Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between HDFC Bank Limited and Humana Inc..

HDFC Bank Limited business model: HDFC Bank makes money mainly from the spread between what it earns on loans and investments and what it pays depositors. Net interest income was roughly two-thirds of FY2025-26 net revenues; the rest came from fees and commissions on cards, payments, third-party distribution and transaction banking, plus treasury and foreign-exchange income. Its three reporting engines are retail banking (mortgages inherited from HDFC Ltd, personal and vehicle loans, credit cards, savings accounts), wholesale banking (working capital, term loans, cash management and trade finance for companies) and treasury. Listed subsidiaries such as HDFC Life, HDFC ERGO, HDFC Asset Management and HDB Financial Services add consolidated earnings.

Humana Inc. business model: Humana runs two reporting segments. The Insurance segment sells individual and group Medicare Advantage plans, stand-alone Medicare Part D drug plans, state Medicaid contracts, and administers TRICARE for the Defense Health Agency. It is paid largely by the federal government on a per-member, per-month basis adjusted for each member's health risk, and keeps the difference between those premiums and medical and pharmacy claims plus operating costs. The CenterWell segment provides services: CenterWell Senior Primary Care clinics, CenterWell Pharmacy (mail-order and specialty), and CenterWell Home Health. CenterWell serves Humana members and members of other plans, and it gives Humana direct influence over care costs for its own seniors.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of HDFC Bank Limited stack up against those of Humana Inc..

HDFC Bank Limited competitive advantage: HDFC Bank's edge is a low-cost retail deposit base gathered through nearly 9,700 branches and DBUs, a long record of tight underwriting (gross NPA ratio of 1.15% at March 2026), and enough digital scale that 98% of financial transactions run online. Salary accounts, credit cards and home loans tie customers into multiple products, which lowers acquisition cost and raises switching friction.

Humana Inc. competitive advantage: Humana's edge is depth in one market. It is the second-largest Medicare Advantage insurer after UnitedHealth, it has decades of experience pricing senior risk, and it owns care-delivery assets built for seniors: CenterWell Senior Primary Care clinics, a large mail-order pharmacy, and CenterWell Home Health. Owning those services lets Humana manage chronic conditions and pharmacy spending directly instead of only paying claims. The tradeoff is concentration: unlike UnitedHealth, CVS/Aetna, or Elevance, it has no large commercial or PBM business to offset a bad Medicare year.

Future prospects matter as much as current results. The growth strategies below explain how HDFC Bank Limited and Humana Inc. each plan to expand from here.

HDFC Bank Limited growth strategy: Since the July 2023 merger with HDFC Ltd, the strategy has shifted from maximising loan growth to rebuilding the funding mix. Management deliberately let advances grow more slowly than deposits in FY2025 and FY2026 to bring the credit-to-deposit ratio down, then resumed faster lending: gross advances grew 15.4% and deposits 14.7% year on year in Q1 FY2026-27. The other levers are cross-selling cards, deposits and insurance to former HDFC Ltd mortgage customers, steady branch additions (234 net in FY2025-26) in semi-urban and rural India, and keeping 98% of financial transactions on digital channels.

Humana Inc. growth strategy: Humana's strategy under Jim Rechtin is to grow Medicare Advantage membership while rebuilding margins and quality scores. Key moves include completing the exit from employer-group commercial medical coverage in 2025, adding more than 1 million MA members for 2026, pruning about 600,000 members' worth of underperforming plans for 2027, investing in Star Ratings operations, and expanding CenterWell Senior Primary Care and CenterWell Pharmacy so that more member care runs through Humana-owned services. It is also bidding for and growing state Medicaid contracts, with a focus on members eligible for both Medicare and Medicaid.

A closer look at the financial trajectory of HDFC Bank Limited and Humana Inc. rounds out the comparison.

HDFC Bank Limited: For FY2025-26 HDFC Bank reported net revenues of ~$22.2 billion (INR 1,91,218.60 crore) (+13.6%) and standalone profit after tax of ~$8.66 billion (INR 74,671.30 crore) (+10.9%), with net interest margin of 3.34% and gross NPAs of 1.15%. The board recommended a final dividend of INR 13 per share. Q1 FY2026-27 standalone profit was ~$2.21 billion (INR 19,060 crore), up about 5% (around 9.8% excluding one-off items in the prior-year quarter), with net interest income up 7%, deposits of ~$368 billion (INR 31.71 lakh crore) (+14.7%), gross advances of ~$355 billion (INR 30.61 lakh crore) (+15.4%) and a capital adequacy ratio of 19.6%. Margin pressure was the main reason the shares fell after the results.

Humana Inc.: Humana's revenue grew from $54.4 billion in 2016 to $129.66 billion in 2025, driven by Medicare Advantage enrollment and higher per-member payments. Profit moved the other way: net income fell from $3.37 billion in 2020 to $1.21 billion in 2024 and $1.19 billion in 2025 as medical costs rose faster than payments. In 2026 revenue is growing fast again: Q2 2026 revenue was $40.89 billion, up 26.2% year over year, with GAAP EPS of $5.73 and adjusted EPS of $7.61. Year-to-date operating cash flow reached $3.22 billion. Full-year 2026 guidance is adjusted EPS of at least $9.00 and GAAP EPS of at least $6.52, reflecting the Star Ratings bonus headwind.